NeuBase Therapeutics Inc (NBSE)
0.4001
-0.01
(-2.44%)
USD |
NASDAQ |
May 07, 16:00
0.4041
0.00 (0.00%)
After-Hours: 20:00
NeuBase Therapeutics Cash from Investing (Quarterly): 0.00 for Sept. 30, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | -0.0049M |
| December 31, 2022 | -0.0498M |
| September 30, 2022 | -0.0288M |
| June 30, 2022 | -0.1706M |
| March 31, 2022 | -0.1484M |
| December 31, 2021 | -0.1239M |
| September 30, 2021 | -0.3516M |
| June 30, 2021 | -1.794M |
| March 31, 2021 | -0.2094M |
| December 31, 2020 | -0.2085M |
| September 30, 2020 | -0.3539M |
| June 30, 2020 | -0.201M |
| March 31, 2020 | -0.0935M |
| December 31, 2019 | -0.0684M |
| September 30, 2019 | -0.6812M |
| June 30, 2019 | 0.00 |
| March 31, 2019 | -0.0041M |
| December 31, 2018 | |
| September 30, 2018 | 0.02M |
| June 30, 2018 | 0.5081M |
| March 31, 2018 | 0.00 |
| December 31, 2017 | |
| September 30, 2017 | 0.005M |
| Date | Value |
|---|---|
| June 30, 2017 | 0.0883M |
| March 31, 2017 | 0.00 |
| December 31, 2016 | -0.0048M |
| September 30, 2016 | -0.0012M |
| June 30, 2016 | -0.0012M |
| March 31, 2016 | -0.0016M |
| December 31, 2015 | -0.0106M |
| September 30, 2015 | -0.0021M |
| June 30, 2015 | -0.096M |
| March 31, 2015 | -0.1869M |
| December 31, 2014 | 0.00 |
| September 30, 2014 | -0.0149M |
| June 30, 2014 | -3.50M |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.00 |
| December 31, 2011 | -0.0334M |
| September 30, 2011 | 0.00 |
| June 30, 2011 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-1.794M
Minimum
Jun 2021
--
Maximum
Jun 2019
-0.2493M
Average
-0.1362M
Median
Cash from Investing (Quarterly) Benchmarks
| Ampio Pharmaceuticals Inc | 0.00 |
| Stoke Therapeutics Inc | 14.77M |
| ABVC BioPharma Inc | 0.1542M |
| MAIA Biotechnology Inc | -- |
| Aprea Therapeutics Inc | -0.0072M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.003M |
| Cash from Financing (Quarterly) | -0.1745M |
| Free Cash Flow | -14.85M |
| Free Cash Flow Per Share (Quarterly) | -0.7262 |
| Free Cash Flow Yield | -1.91K% |